Cardiff Oncology, Inc. SEC filings CRDF
Cardiff Oncology, Inc. has 1,001 filings in SEC EDGAR's recent list, going back to May 23, 2012. Its latest annual report, Form ARS, was filed on Apr 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (officer or director change, bylaw or fiscal year change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 3 | Initial insider ownership | Oct 27, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Oct 27, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Oct 22, 2026 | Oct 22, 2026 |
| 8-K |
Current report
Material agreement, Regulation FD disclosure
|
Sep 14, 2026 | Sep 14, 2026 |
| DEFA14A | Additional proxy material | Aug 26, 2026 | — |
| DEF 14A | Proxy statement | Aug 26, 2026 | Aug 26, 2026 |
| PRE 14A | Preliminary proxy statement | Aug 14, 2026 | Aug 14, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 27, 2026 | — |
| S-8 | Employee stock plan registration | Jul 21, 2026 | — |
| 4 | Insider transaction | Jul 16, 2026 | Jul 14, 2026 |
| 4 | Insider transaction | Jul 16, 2026 | Jul 14, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 16, 2026 | Jul 14, 2026 |
| 424B5 | Prospectus supplement | Jul 16, 2026 | — |
| 4 | Insider transaction | Jun 22, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 22, 2026 | Jun 18, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2026 | Jun 11, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 3, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Material agreement
|
May 29, 2026 | May 27, 2026 |
| 8-K |
Current report
Other events
|
May 19, 2026 | May 19, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 4 | Insider transaction | Apr 28, 2026 | Apr 27, 2026 |
| 3 | Initial insider ownership | Apr 28, 2026 | Apr 27, 2026 |
| DEFA14A | Additional proxy material | Apr 23, 2026 | — |
| DEF 14A | Proxy statement | Apr 23, 2026 | Jun 11, 2026 |
| ARS | Annual report to shareholders | Apr 23, 2026 | Dec 31, 2025 |
| 3 | Initial insider ownership | Apr 16, 2026 | Apr 6, 2026 |
| 4/A | Filing | Apr 16, 2026 | Apr 6, 2026 |
| 4 | Insider transaction | Apr 16, 2026 | Apr 14, 2026 |
| 4 | Insider transaction | Apr 16, 2026 | Apr 6, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Apr 9, 2026 | Apr 6, 2026 |
| 4 | Insider transaction | Apr 2, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Apr 2, 2026 | Mar 27, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 25, 2026 | Feb 25, 2026 |
| 8-K |
Current report
Acquisition or sale of assets
|
Feb 24, 2026 | Feb 24, 2026 |
| 10-K | Annual report | Feb 24, 2026 | Dec 31, 2025 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 13, 2026 |
| 4 | Insider transaction | Feb 18, 2026 | Feb 17, 2026 |
| 3 | Initial insider ownership | Feb 9, 2026 | Jan 27, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Jan 27, 2026 | Jan 27, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 6, 2025 | Nov 6, 2025 |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| S-8 | Employee stock plan registration | Aug 28, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| 4 | Insider transaction | Jul 31, 2025 | Jul 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jul 29, 2025 | Jul 29, 2025 |
| 10-Q | Quarterly report | Jul 29, 2025 | Jun 30, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 29, 2025 | — |
| 3 | Initial insider ownership | Jul 8, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 30, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 27, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 26, 2025 | Jun 26, 2025 |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 17, 2025 | Jun 13, 2025 |
| EFFECT | Filing | May 13, 2025 | — |
| CORRESP | Letter to the SEC | May 12, 2025 | — |
| S-3/A | Filing | May 8, 2025 | — |
| 8-K |
Current report
Results of operations
|
May 8, 2025 | May 8, 2025 |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| DEFA14A | Additional proxy material | Apr 30, 2025 | — |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 29, 2025 | Apr 29, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 23, 2025 | — |
| 4 | Insider transaction | Mar 13, 2025 | Mar 11, 2025 |
| 4 | Insider transaction | Mar 13, 2025 | Mar 11, 2025 |
| 4 | Insider transaction | Mar 13, 2025 | Mar 11, 2025 |
| 4 | Insider transaction | Mar 13, 2025 | Mar 11, 2025 |
| UPLOAD | Letter from the SEC | Mar 6, 2025 | — |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| S-3 | Shelf registration | Feb 27, 2025 | — |
| 10-K | Annual report | Feb 27, 2025 | Dec 31, 2024 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2025 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jan 6, 2025 | Jan 3, 2025 |
| 4 | Insider transaction | Dec 18, 2024 | Dec 16, 2024 |
| SCHEDULE 13G | Ownership over 5% (passive) | Dec 17, 2024 | — |
| 4 | Insider transaction | Dec 16, 2024 | Dec 12, 2024 |
| 4 | Insider transaction | Dec 12, 2024 | Dec 11, 2024 |
| 424B5 | Prospectus supplement | Dec 11, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Dec 10, 2024 | Dec 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 10, 2024 | Dec 10, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 24, 2024 | — |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jul 1, 2024 | Jun 27, 2024 |
| 4 | Insider transaction | Jul 1, 2024 | Jun 27, 2024 |
| 4 | Insider transaction | Jul 1, 2024 | Jun 27, 2024 |
| 4 | Insider transaction | Jul 1, 2024 | Jun 27, 2024 |
| 4 | Insider transaction | Jul 1, 2024 | Jun 27, 2024 |
| 4 | Insider transaction | Jul 1, 2024 | Jun 27, 2024 |
| S-8 | Employee stock plan registration | Jul 1, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 20, 2024 | Jun 20, 2024 |
| DEFA14A | Additional proxy material | Jun 17, 2024 | — |
| DEFA14A | Additional proxy material | Jun 3, 2024 | — |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Jun 3, 2024 | May 30, 2024 |
| 8-K |
Current report
Results of operations
|
May 2, 2024 | May 2, 2024 |
| 10-Q | Quarterly report | May 2, 2024 | Mar 31, 2024 |
| DEFA14A | Additional proxy material | Apr 25, 2024 | — |
| ARS | Annual report to shareholders | Apr 25, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 25, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 8, 2024 | Apr 8, 2024 |
| S-8 | Employee stock plan registration | Mar 27, 2024 | — |
| 4 | Insider transaction | Mar 7, 2024 | Mar 7, 2024 |
| 4 | Insider transaction | Mar 7, 2024 | Mar 7, 2024 |
| 4 | Insider transaction | Mar 7, 2024 | Mar 7, 2024 |
| 4 | Insider transaction | Mar 7, 2024 | Mar 7, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 29, 2024 | Feb 29, 2024 |
| 10-K | Annual report | Feb 29, 2024 | Dec 31, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 6, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 8, 2024 | Jan 8, 2024 |
| 4 | Insider transaction | Dec 19, 2023 | Dec 19, 2023 |
| 4 | Insider transaction | Nov 14, 2023 | Nov 10, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 2, 2023 | Nov 2, 2023 |
| 10-Q | Quarterly report | Nov 2, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 26, 2023 | Sep 26, 2023 |
| 8-K |
Current report
Results of operations, Bylaw or fiscal year change
|
Aug 9, 2023 | Aug 8, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 7, 2023 | Aug 7, 2023 |
| 8-K |
Current report
Other events
|
Jul 24, 2023 | Jul 24, 2023 |
| 8-K |
Current report
Other events
|
Jun 20, 2023 | Jun 20, 2023 |
| 4 | Insider transaction | Jun 20, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 20, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 20, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 20, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 20, 2023 | Jun 15, 2023 |
| 4 | Insider transaction | Jun 20, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Results of operations
|
May 4, 2023 | May 4, 2023 |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| ARS | Annual report to shareholders | Apr 27, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 27, 2023 | — |
| DEF 14A | Proxy statement | Apr 27, 2023 | — |
| 4 | Insider transaction | Mar 16, 2023 | Mar 15, 2023 |
| 4 | Insider transaction | Mar 16, 2023 | Mar 15, 2023 |
| 4 | Insider transaction | Mar 16, 2023 | Mar 15, 2023 |
| 4 | Insider transaction | Mar 16, 2023 | Mar 15, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 2, 2023 | Mar 2, 2023 |
| 10-K | Annual report | Mar 2, 2023 | Dec 31, 2022 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 14, 2023 | — |
| 3 | Initial insider ownership | Feb 9, 2023 | Jan 30, 2023 |
| SC 13G/A | Amended ownership over 5% (passive) | Feb 9, 2023 | — |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 2, 2023 | Feb 2, 2023 |
| SC 13G | Ownership over 5% (passive) | Jan 26, 2023 | — |
| SC 13D/A | Amended ownership over 5% (active) | Jan 26, 2023 | — |
| 4 | Insider transaction | Nov 29, 2022 | Nov 25, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 3, 2022 | Nov 3, 2022 |
| 10-Q | Quarterly report | Nov 3, 2022 | Sep 30, 2022 |
| 4 | Insider transaction | Oct 11, 2022 | Sep 16, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 3, 2022 | Oct 3, 2022 |
| 4 | Insider transaction | Sep 20, 2022 | Sep 19, 2022 |
| 4 | Insider transaction | Sep 19, 2022 | Sep 15, 2022 |
| 4 | Insider transaction | Sep 19, 2022 | Sep 15, 2022 |
| 4 | Insider transaction | Sep 19, 2022 | Sep 16, 2022 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 12, 2022 | Sep 10, 2022 |
| 8-K |
Current report
Other events
|
Sep 6, 2022 | Sep 6, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2022 | Aug 4, 2022 |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| S-8 | Employee stock plan registration | Jul 12, 2022 | — |
| SC 13G | Ownership over 5% (passive) | Jul 8, 2022 | — |
| 4 | Insider transaction | Jul 6, 2022 | Jul 5, 2022 |
| 8-K/A |
Amended current report
Shareholder vote results
|
Jun 14, 2022 | Jun 9, 2022 |
| 4 | Insider transaction | Jun 9, 2022 | Jun 9, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2022 | Jun 9, 2022 |
| 8-K |
Current report
Results of operations
|
May 5, 2022 | May 5, 2022 |
| 10-Q | Quarterly report | May 5, 2022 | Mar 31, 2022 |
| EFFECT | Filing | Apr 25, 2022 | — |
| CORRESP | Letter to the SEC | Apr 21, 2022 | — |
| DEFA14A | Additional proxy material | Apr 15, 2022 | — |
| DEF 14A | Proxy statement | Apr 14, 2022 | Jun 9, 2022 |
| UPLOAD | Letter from the SEC | Apr 14, 2022 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 12, 2022 | Apr 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 8, 2022 | Apr 8, 2022 |
| S-3 | Shelf registration | Apr 5, 2022 | — |
| 4 | Insider transaction | Mar 11, 2022 | Mar 9, 2022 |
| 4 | Insider transaction | Mar 10, 2022 | Mar 9, 2022 |
| 4 | Insider transaction | Mar 10, 2022 | Mar 9, 2022 |
| 4 | Insider transaction | Mar 10, 2022 | Mar 9, 2022 |
| 4 | Insider transaction | Mar 10, 2022 | Mar 9, 2022 |
| 4 | Insider transaction | Mar 10, 2022 | Mar 9, 2022 |
| 4 | Insider transaction | Mar 10, 2022 | Mar 9, 2022 |
| 4 | Insider transaction | Mar 10, 2022 | Mar 9, 2022 |
| 4 | Insider transaction | Mar 10, 2022 | Mar 9, 2022 |
| 4 | Insider transaction | Mar 10, 2022 | Mar 9, 2022 |
| 4 | Insider transaction | Mar 10, 2022 | Mar 9, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2022 | Feb 24, 2022 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- CRDF (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1213037
- Former names
- Trovagene, Inc. (until May 7, 2020); TrovaGene Inc. (until Mar 4, 2013); XENOMICS INC (until Jun 3, 2009); USED KAR PARTS INC (until Jun 30, 2004)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.